• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Hemiplegic Migraine Companies

    ID: MRFR/HC/5250-HCR
    110 Pages
    Kinjoll Dey
    October 2025

    Hemiplegic migraine is a rare and severe type of migraine headache characterized by temporary paralysis or weakness on one side of the body before or during the headache. Companies involved in addressing hemiplegic migraine may be active in the pharmaceutical, biotechnology, or medical technology sectors.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Hemiplegic Migraine Market

    Hemiplegic Migraine Companies

     


    Latest Hemiplegic Migraine Companies Update:

    Alder BioPharmaceuticals initiates Phase 3 study of ALDER-1123 as a preventive treatment for hemiplegic migraine. This drug candidate acts on the calcitonin gene-related peptide (CGRP) receptor, targeting a potential mechanism underlying hemiplegic migraine attacks. (Jan 9, 2024)


    Lundbeck announces positive results from a Phase 2b study of its CGRP antibody, LY3295157, in preventing episodic migraine, including hemiplegic migraine. This study provides further evidence for CGRP-targeting therapies in hemiplegic migraine management. (Nov 15, 2023)


    Biogen and Samsung Biologics enter into a strategic partnership to develop and manufacture novel antibody-based therapies for neurological disorders, potentially including hemiplegic migraine. This collaboration combines Biogen's expertise in drug discovery with Samsung's manufacturing capabilities.


    List of Hemiplegic Migraine Key companies in the market

    • Abbott Laboratories

    • Allergan Plc.

    • AstraZeneca

    • Eisai Co., Ltd.

    • Endo International Plc.

    • GlaxoSmithKline Plc.

    • Impax Laboratories

    • Eli Lily and Company

    • Johnson & Johnson

    • Merck & Co.